Interestingly, the expression level of DNA Damage Inducible Transcript 4 (DDIT4) did not present a significant difference between the high- and low-TAS groups, indicating that its role in ESCC prognosis might be limited or non-significant. This evidence concerns the gene DDIT4 and esophageal squamous cell carcinoma.